Australia markets open in 7 hours 46 minutes

Humacyte, Inc. (HUMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.9600+0.0300 (+0.61%)
As of 12:14PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
80,536
76,550
63,260
61,341
54,078
Selling general and administrative
20,470
20,390
22,883
21,130
12,013
Total operating expenses
101,006
96,940
84,578
81,208
64,600
Operating income or loss
-101,006
-96,940
-84,578
-81,208
-64,600
Interest expense
6,716
6,599
6,200
4,348
2,202
Total other income/expenses net
-3,004
-12,704
76,184
59,063
-
Income before tax
-105,703
-110,776
-11,965
-26,477
-66,524
Income from continuing operations
-105,703
-110,776
-11,965
-26,477
-66,524
Net income
-105,703
-110,776
-11,965
-26,477
-66,524
Net income available to common shareholders
-105,703
-110,776
-11,965
-26,477
-66,524
Basic EPS
-0.87
-1.07
-0.12
-0.66
-0.65
Diluted EPS
-0.87
-1.07
-0.12
-0.66
-0.65
Basic average shares
103,309
103,420
103,051
39,970
103,003
Diluted average shares
103,309
103,420
103,051
39,970
103,003